About ChromaTan
ChromaTan is a company based in State College (United States) founded in 2009.. ChromaTan has raised $5.32 million across 8 funding rounds from investors including NIH, HHS and Ben Franklin Technology Partners. ChromaTan offers products and services including Kascade BioRMB. ChromaTan operates in a competitive market with competitors including Upfront Chromatography, Sepax Technologies, Natrix Separations, Reach Separations and PharmaFluidics, among others.
- Headquarter State College, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Chromatan Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.32 M (USD)
in 8 rounds
-
Latest Funding Round
$2 M (USD), Grant
May 30, 2024
-
Investors
NIH
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ChromaTan
ChromaTan offers a comprehensive portfolio of products and services, including Kascade BioRMB. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Column-free system for efficient bioprocessing and purification of modalities.
Unlock access to complete
Founder Team
1 people
Product Management Team
1 people
Data Analysis and Operations Team
1 people
Unlock access to complete
Funding Insights of ChromaTan
ChromaTan has successfully raised a total of $5.32M across 8 strategic funding rounds. The most recent funding activity was a Grant round of $2 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Grant — $2.0M
-
First Round
First Round
(22 Aug 2011)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Grant - ChromaTan | Valuation |
investors |
|
| May, 2024 | Amount | Grant - ChromaTan | Valuation |
investors |
|
| Jun, 2019 | Amount | Series A - ChromaTan | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ChromaTan
ChromaTan has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Ben Franklin Technology Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investment and support are provided for Pennsylvania's tech-based companies.
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in life sciences technologies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ChromaTan
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ChromaTan
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Chromatan Comparisons
Competitors of ChromaTan
ChromaTan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Upfront Chromatography, Sepax Technologies, Natrix Separations, Reach Separations and PharmaFluidics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Chromatography technologies for protein separation and biomolecule recovery are provided.
|
|
| domain | founded_year | HQ Location |
Solutions for chromatographic biomolecular separation are developed and provided.
|
|
| domain | founded_year | HQ Location |
Provider of proprietary filtration solutions for life science
|
|
| domain | founded_year | HQ Location |
Small molecule analysis and purification services are provided using chromatography.
|
|
| domain | founded_year | HQ Location |
Microchip liquid chromatography cartridges are supplied for nano-LC applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Chromatan
Frequently Asked Questions about ChromaTan
When was ChromaTan founded?
ChromaTan was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Where is ChromaTan located?
ChromaTan is headquartered in State College, United States. It is registered at State College, Pennsylvania, United States.
Is ChromaTan a funded company?
ChromaTan is a funded company, having raised a total of $5.32M across 8 funding rounds to date. The company's 1st funding round was a Series A of $2.72M, raised on Aug 22, 2011.
What does ChromaTan do?
ChromaTan was founded in 2009 in State College, United States, focusing on biomanufacturing separation processes. A column-free, single-use continuous countercurrent tangential chromatography (CCTC) platform has been developed as an alternative to traditional column methods. Endorsements for the technology have been received from MedImmuneAstraZeneca, Regeneron, and NRC Canada. A 2.5 million contract from the FDA was awarded in September 2017 to advance continuous purification for single-use bio-manufacturing.
Who are the top competitors of ChromaTan?
ChromaTan's top competitors include Sepragen, Sepax Technologies and Semba Biosciences.
What products or services does ChromaTan offer?
ChromaTan offers Kascade BioRMB.
Who are ChromaTan's investors?
ChromaTan has 7 investors. Key investors include NIH, HHS, Ben Franklin Technology Partners, NIH SBIR/STTR, and LSG Investments.